Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults

NCT01155037 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

450

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection

Interventions

BIOLOGICAL: Adjuvanted vaccine against H1N1 influenza virus (GSK)
BIOLOGICAL: Adjuvanted vaccine against H1N1 influenza virus (GSK)
BIOLOGICAL: Adjuvanted vaccine against H1N1 influenza virus (GSK)

Sponsor

Oswaldo Cruz Foundation

Collaborators

[object Object]